Shares of biotech company Sarepta Therapeutics (NASDAQ:SRPT) fell 44.4% in the afternoon session after the company reported a ...

Shares in both companies were down following news of the second death, casting fresh safety concerns over Elevidys.

Advanced Micro Devices (AMD) stock is on the rise after Piper Sandler analysts lifted their price target for the stock to ...

Here are some of the stories Wall Street is watching on Monday, June 16. Michael Saylor's Strategy (MSTR) bought $1.05 billion worth of bitcoin (BTC-USD), according to an SEC filing. EchoStar (SATS) ...

Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, today provided a safety ...

Sarepta Therapeutics (NasdaqGS:SRPT) recently announced that its SRP-9003 gene therapy received a platform technology designation from the FDA, and updated safety protocols for ELEVIDYS in the UK.

Sarepta's shares sink as second Elevidys-linked death triggers safety concerns, dosing halts and trial pauses.

BMO Capital and Piper Sandler downgraded Sarepta Therapeutics (NASDAQ:SRPT) after the company reported a second death linked to its gene therapy Elevidys in a non-ambulatory Duchenne muscular ...

The most talked about and market moving research calls around Wall Street are now in one place. Here are today’s research ...

Shares of Sarepta Therapeutics plunged Monday after the biotech drugmaker reported a second death in connection with its gene ...

With FDA platform technology designation for its viral vector, SRPT can fast-track other therapies using the same gene-delivery method.

Sarepta Therapeutics (SRPT) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.